Short-term oral corticosteroid use and risk for major adverse cardiovascular events within one year in patients with chronic obstructive pulmonary disease, a Danish registry-based cohort study
Short-term OCS use was not associated with an increased risk of MACE within 365 days among outpatients with COPD.
Authors
- Barbara Bonnesen
- P Sivapalan
- Gertrud Baunsgaard-Pedersen
- Jens Ulrik Stæhr Jensen
- Josefin Eklöf
Institutions
- University of Copenhagen (DK)
Publication Details
- Journal
- European Clinical Respiratory Journal
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1080/20018525.2026.2616846
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00